Form 4: Veru Inc. CEO Mitchell Steiner Awarded Stock Options
SEC Form 4 Filing
Veru Inc.'s CEO, Mitchell Steiner, received an annual stock option grant for fiscal year 2024.
Summary
- On May 7, 2024, Mitchell Steiner, the President and CEO of Veru Inc., was granted 376,000 stock options.
- The exercise price of these options is $1.63.
- The options vest in three equal annual installments starting on May 7, 2025, and expire on May 7, 2034.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it aligns management and shareholder interests.
Positives
- The granting of stock options to the CEO aligns his interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the CEO.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the options.
Industry Context
Stock option grants are a common form of executive compensation in the pharmaceutical industry, aligning management's interests with shareholder value creation.
Comparison to Industry Standards
- Executive compensation packages, including stock options, are common in publicly traded companies like Veru Inc.
- Comparable companies in the pharmaceutical sector, such as Amgen, Gilead Sciences, and Pfizer, also utilize stock options as part of their executive compensation plans.
- The size and vesting schedule of the options are generally determined by factors such as company performance, industry benchmarks, and individual contributions.
Stakeholder Impact
- Shareholders may view the option grant as a positive incentive for the CEO to improve company performance.
- Employees may see the grant as a sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 05/07/2024 | Date of transaction: CEO Mitchell Steiner was granted stock options. |
| 05/07/2025 | First vesting date for one-third of the options. |
| 05/07/2026 | Second vesting date for one-third of the options. |
| 05/07/2027 | Third vesting date for one-third of the options. |
| 05/07/2034 | Expiration date of the options. |
| 05/09/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.